Jeffery J. Anderson, Ph.D.

Back to Jobs

Jeffery J. Anderson, Ph.D., is our Vice President, Clinical Sciences and previously served as Senior Director since joining Otonomy in May 2017. Dr. Anderson is a neuroscientist and pharmacologist with over 25 years of research and clinical development experience, primarily in neuroscience therapeutic areas. Prior to joining Otonomy, he served as Associate Director/Program Leader, Clinical Development at Dart Neuroscience and led drug development for compounds targeting stroke recovery and cognitive disorders. Previously, he served in various leadership roles at Cypress Bioscience and supported the development and NDA approval of SavellaTM (milnacipran) for fibromyalgia and the advancement of several clinical programs for schizophrenia and cognitive impairment. Prior to joining Cypress Bioscience, Dr. Anderson served in research leadership roles at Merck and at SIBIA Neurosciences focusing on drug discovery and development of compounds for Alzheimer’s disease, pain, and psychiatric disorders. Dr. Anderson was a post-doctoral fellow at the National Institute of Neurological Disorders and Stroke, Experimental Therapeutics Branch. He obtained his Ph.D. in Pharmacology & Toxicology at Indiana University School of Medicine, and Master’s and Bachelor’s degrees in Biology at the University of Dayton.

Apply Now